Lymecycline

This page contains recent news articles, when available, and an overview of Lymecycline but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Lymecycline
(when available)

Pharmacology and use:
Lymecycline is a tetracycline antibiotic that is commonly prescribed by medical doctors for infections and to treat acne. It may also be used to treat urinary tract infections, gum disease, and other bacterial infections such as gonorrhea and chlamydia. Lymecycline is also used commonly as a prophylactic treatment for infection by Bacillus anthracis (anthrax). It is also effective against Yersinia pestis and malaria and is also prescribed for the treatment of Lyme disease. Lymecycline inhibits cell growth by inhibiting translation. For the treatment of bacterial infection including: Brucellosis; Mycoplasma infection; Trachoma; Chronic bronchitis; Acne vulgaris; Chlamydial infection

Mechanism Of Action:
Lymecycline inhibits cell growth by inhibiting translation. It binds to the 30S ribosomal subunit and prevents the amino-acyl tRNA from binding to the A site of the ribosome. The binding is reversible in nature. Lymecycline is lipophilic and can easily pass through the cell membrane or passively diffuses through porin channels in the bacterial membrane. Cells become resistant to Lymecycline by at least two mechanisms: efflux and ribosomal protection. In efflux, a resistance gene encodes a membrane protein that actively pumps Lymecycline out of the cell. This is the mechanism of action of the tetracycline resistance gene on the artificial plasmid pBR322. In ribosomal protection, a resistance gene encodes a protein which binds to the ribosome and prevents Lymecycline from acting on the ribosome.

News Articles on Lymecycline

Clinical news: DTB opposes minocycline for treatment of acne.(drug …  -  Aug 26, 2006
Although minocycline has a once-daily dosage regimen and does not need to be taken on an empty stomach (unlike older tetracyclines), lymecycline and ... $4.95 - Chemist & Druggist - ECNext

A common problem that need not be suffered in silence  -  Nov 10, 2008
Doxycycline is a good starting point and if it is ineffective after three months it can be replaced by lymecycline. Oxytetracycline is poorly absorbed by ... WalesOnline

Clinical: The management of acne.  -  May 25, 2007
Alternatives to minocycline include doxycycline 100mg once daily and lymecycline 408mg daily. The anti-androgen cyproterone acetate is usually given at a ... Free with registration - GP - AccessMyLibrary.com

Common and alternate oral antibiotic therapies for acne vulgaris: a...  -  Sep 1, 2007
...(5) (Lymecycline, a second-generation tetracycline introduced in 1963, is used outside of the US for acne and will not be discussed further here. ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com

Five things...you may not know about rosacea.  -  Nov 16, 2006
If compliance with oxytetracycline is a problem, lymecycline 408mg once daily (unlicensed) or doxycycline 100mg daily is a useful alternative. ... Free with registration - Pulse - AccessMyLibrary.com

PulseClinical: Need to know acne Rosacea.(Disease/Disorder overview)  -  Oct 10, 2007
Lymecycline 408mg once a day or doxycycline 100mg once a day are alternatives. If intolerant or allergic to the tetracyclines, or pregnant or breast- ... Free with registration - Pulse - AccessMyLibrary.com

PulseClinical: JOURNAL SHORTCUTS - RECENT PAPERS ON …  -  Oct 31, 2007
Lymecycline and doxycycline have once daily dose regimes, are as effective and cheaper. How should you treat warts in a cash-strapped NHS? ... Free with registration - Pulse - AccessMyLibrary.com

Prescribing notes: Minocycline costs NHS millions.(national health …  -  Sep 11, 2006
Other alternatives such as lymecycline and oxytetracycline would have cost the NHS #5.4m and #5m, respectively. Minocycline is often prescribed because it ... $4.95 - Pharmacy Today - ECNext

Expert committee recommendations for acne management.(SPECIAL …  -  Sep 1, 2006
Additional antibiotics commonly used for the treatment of acne in specific instances include lymecycline (150-300 mg daily before meals) for use outside of ... $4.95 - Pediatrics - ECNext

Brand Names/Synonyms:
Lymecycline is also known by the following brand names and/or synonymsAUREOMYCIN; Acronize; Acronize Pd; Aureocarmyl; Aureociclin; Aureociclina; Aureocina; Aureocycline; Aureomicina; Aureomycin Hydrochloride; Aureomycin Monohydrochloride; Aureomycin a-377; Aureomykoin; Aurofac; Aurofac 10; Auxeomycin; B-Aureo; Biomitsin; Biomitsin Hydrochloride; Biomycin; Biomycin A; Biomycin Hydrochloride; Biovetin; C4881; CHEMBANK901; CLTC; CTC; Centraureo; Chlorotetracycline; Chlorotetracycline Hydrochloride; Chlortetracyclin; Chlortetracycline; Chlortetracycline Hydrochloride; Chlortetracyclinium Chloride; Chrusomykine; Chrysomykine; Clorocipan; Duomycin; Flamycin; Isphamycin; Lymecycline; Orospray; Psittacin Hydrochloride; Tetra 5; Tetralysal; Tocopherex; U-6780

Drug Category:
Lymecycline is categorized under the following by the FDA: Antiprotozoals; Anti-bacterial Agents; ATC:J01AA04

Dosage Forms:
Capsule

Absorption:
Not Available

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
2-(amino-hydroxy-methylidene)-7-chloro-4-dimethylamino-6,10,11,12a-tetrahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy